Epigenetic silencing of WNT5A in Epstein-Barr virus-associated gastric carcinoma
Epigenetic silencing of WNT5A in Epstein-Barr virus-associated gastric carcinoma
复制标题
DOI:
10.1007/s00705-012-1481-x
复制
发表时间:
2012
影响因子:
2.7
通讯作者:
Xia Liu;Yun Wang;Xiaofeng Wang;Zhi-fu Sun;Lili Li;Q. Tao;B. Luo
中科院分区:
文献类型:
--
作者:
Xia Liu;Yun Wang;Xiaofeng Wang;Zhi-fu Sun;Lili Li;Q. Tao;B. Luo
Epstein-Barr virus (EBV) is responsible for the development of multiple tumors, including EBV-associated gastric carcinoma (EBVaGC), but little is known about its mechanisms in EBVaGC.WNT5Aexpression and promoter methylation were measured in 5 EBV-positive and 15 EBV-negative GC cell lines. The methylation status of 23 EBV-positive and 25 EBV-negative paired tumor/normal tissue samples was also examined. EBV-positive GC had no or very low expression ofWNT5Abut a high level of methylation in the promoter region. In contrast, EBV-negative GC had higherWNT5Aexpression and a lower level of promoter methylation. The reducedWNT5Aexpression could be restored by treatment with Aza, a methyltransferase inhibitor. Increased expression ofWNT5Ain vitroinhibited β-catentin expression in EBVaGC cells (SNU719). These results suggest that hypermethylation ofWNT5Ainduced by EBV may contribute to the development of EBVaGC. Ectopic introduction ofWNT5Amay have preventive/therapeutic potential for tumors with silencedWNT5A.